Cell cycle activation has been associated with varying types of neurological disorders including brain injury. Cyclin D1 is a critical modulator of cell cycle activation and upregulation of Cyclin D1 in neurons contributes to the pathology associated with traumatic brain injury (TBI). Mitochondrial mass is a critical factor to maintain the mitochondrial function, and it can be regulated by different signaling cascades and transcription factors including NRF1. However, the underlying mechanism of how TBI leads to impairment of mitochondrial mass following TBI remains obscure. Our results indicate that augmentation of CyclinD1 attenuates mitochondrial mass formation following TBI. To elucidate the molecular mechanism, we found that Cyclin D1 interacts with a transcription factor NRF1 in the nucleus and prevents NRF1's interaction with p300 in the pericontusional cortex following TBI. As a result, the acetylation level of NRF1 was decreased, and its transcriptional activity was attenuated. This event leads to a loss of mitochondrial mass in the pericontusional cortex following TBI. Intranasal delivery of Cyclin D1 RNAi immediately after TBI rescues transcriptional activation of NRF1 and recovers mitochondrial mass after TBI.
Introduction
Neurons are post-mitotic cells have permanently entered G0 phase and were incapable of entering the cell cycle (Frade and OvejeroBenito, 2015) . However, recent studies have shown that matured differentiated neurons can enter into the cell-cycle reentry phase which ultimately results in cell death rather than proliferation (Herrup and Yang, 2007; Kabadi et al., 2012; Kranenburg et al., 1996) . The sequential activation of Ser/Thr kinases called the cyclin-dependent kinases (CDK), and their positive regulators (Kabadi and Faden, 2014; Malumbres, 2014) such as activation of Cyclin D1 are essential to maintaining the different stages of cell cycle. Dr. Faden and his associates have convincingly shown that cell cycle activation is responsible for cell death in apoptosis in the post-mitotic cells like neuron (Kabadi and Faden, 2014) . In addition, activation of the cell cycle in microglial cells results in the release of pro-inflammatory and neurotoxic molecules which contributes significantly to the pathology of TBI (Byrnes and Faden, 2007; Byrnes et al., 2007; Di Giovanni et al., 2005; Hilton et al., 2008; Wu et al., 2011) . However, its role in mitochondrial function is mostly unknown.
Mitochondrial dysfunction has been implicated in the TBI pathology (Fischer et al., 2016; Hill et al., 2017; Singh et al., 2006) and the maintenance of the mitochondrial mass has been suggested to function as a critical factor to maintain the mitochondrial function and production of ATP inside cells (Wang et al., 2017b) . The proper intracellular distribution of mitochondria is assumed to be critical for normal physiology of neuronal cells (Cheng et al., 2012; Li et al., 2004) . The changes in mitochondrial mass are correlated with the development and morphological plasticity of spines (Cheng et al., 2010; Li et al., 2004) . Mitochondrial mass, by itself, represents the net balance between rates of biogenesis and degradation (Dominy and Puigserver, 2013) and mitochondrial mass can be regulated by mitochondrial DNA (mtDNA) content which is known to be synthesized inside the nucleus through activation of several transcription factors (Dominy and Puigserver, 2013; Jornayvaz and Shulman, 2010) . PGC-1α is a cotranscriptional regulation factor that induces mitochondrial mass by activating different transcription factors, including NRF1, which promotes the expression of mitochondrial transcription factor A or TFAM (Dominy and Puigserver, 2013; Jornayvaz and Shulman, 2010; Scarpulla, 2011; Ventura-Clapier et al., 2008) . NRF1 is an essential contributor to the sequence of events leading to the increase in transcription of key mitochondrial enzymes, and it has been shown to regulate TFAM, which drives transcription and replication of mtDNA (Jezierska-Drutel et al., 2013; Scarpulla, 2008) . Previously it was shown that NRF1 could interact and acetylated by an acetyltransferase p300/CBP and acetylation of NRF1 enhances its transcriptional
